Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | AMGN | REGN | VRTX | GILD |
| Company | Roivant Sciences Ltd | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.23 | 317.11 | 1,037.50 | 460.00 | 84.25 |
| High | 11.36 | 319.73 | 1,038.81 | 462.13 | 84.93 |
| Low | 11.14 | 315.46 | 1,011.36 | 452.26 | 84.01 |
| Last | 11.21 | 317.48 | 1,014.59 | 453.55 | 84.17 |
| Change | -0.07 | -2.25 | -25.68 | -8.59 | -0.57 |
| % Change | -0.62% | -0.70% | -2.47% | -1.86% | -0.67% |
| Volume | 4,386,000 | 1,525,200 | 797,500 | 992,800 | 4,086,000 |
| 20-Day Average Volume | 10,178,215 | 2,135,675 | 666,300 | 981,810 | 7,972,160 |
| Previous Close | 11.28 | 319.73 | 1,040.27 | 462.14 | 84.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 327.16 | 1,100.53 | 469.88 | 82.88 |
| 20-Day Raw Stochastic | 3.66% | 19.70% | 3.81% | 3.40% | 82.48% |
| 20-Day Relative Strength | 42.22% | 43.26% | 32.18% | 39.60% | 66.18% |
| Weighted Alpha | +5.71 | +16.94 | +16.38 | +20.78 | +18.62 |
| Today's Opinion | 48% Buy | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Previous Opinion | 56% Buy | 24% Buy | 24% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 96% Buy | 100% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/26/24 | -0.51% since 09/26/24 | -2.44% since 09/26/24 | -2.07% since 09/26/24 | +1.36% since 09/26/24 |
| Low | 11.14 on 10/03/24 | 315.46 on 10/03/24 | 1,011.36 on 10/03/24 | 452.26 on 10/03/24 | 82.82 on 10/01/24 |
| High | 11.66 on 09/27/24 | 327.98 on 09/27/24 | 1,070.00 on 09/27/24 | 472.31 on 10/01/24 | 85.43 on 10/02/24 |
| 1-Month | |||||
| %Chg | -4.76% since 09/03/24 | -3.94% since 09/03/24 | -13.19% since 09/03/24 | -4.66% since 09/03/24 | +5.61% since 09/03/24 |
| Low | 11.14 on 10/03/24 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 452.26 on 10/03/24 | 77.74 on 09/05/24 |
| High | 13.06 on 09/09/24 | 339.17 on 09/23/24 | 1,182.31 on 09/04/24 | 490.15 on 09/16/24 | 85.43 on 10/02/24 |
| 3-Month | |||||
| %Chg | +6.97% since 07/03/24 | +2.62% since 07/03/24 | -0.93% since 07/03/24 | -3.56% since 07/03/24 | +26.40% since 07/03/24 |
| Low | 10.00 on 08/05/24 | 306.59 on 08/07/24 | 1,008.41 on 09/25/24 | 452.26 on 10/03/24 | 66.01 on 07/05/24 |
| High | 13.06 on 09/09/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| 6-Month | |||||
| %Chg | -2.61% since 04/03/24 | +15.69% since 04/03/24 | +6.69% since 04/03/24 | +10.94% since 04/03/24 | +18.73% since 04/03/24 |
| Low | 10.00 on 08/05/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 13.06 on 09/09/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,332,784 | 171,514,368 | 114,623,184 | 119,256,624 | 105,573,584 |
| Shares Outstanding, K | 738,722 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 124,800,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 4,348,930,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 55,130,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | 95,300,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 1.24 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 08/08/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.22 | 27.25 | 0.00 | 17.86 |